Autopsy report · NCT01082653

Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis

“Suspended due to lack of funding.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 6 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1

Sponsor

TCA Cellular Therapy

Sponsor type

Industry

Conditions

Amyotrophic Lateral Sclerosis

Interventions

autologous bone marrow-derived stem cells

Participants

6 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Stem Cells in NF1 Patients With Tumors of the Central Nervous System
  “Suspended due to cessation of funding” (85% match in meaning)
• Exhaled Nitric Oxide in Asthma Management
  “suspended due to lack of data.” (84% match in meaning)
• Dose-response of Talus Mobilizations
  “Suspended due to the covid-19 pandemic.” (75% match in meaning)
• The SmokeFree App Smoking Cessation Study
  “Suspended due to COVID19 pandemic.” (73% match in meaning)
• MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
  “Funding suspended prior to completing enrollment of all participants.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.